プラーク修飾および除去デバイスの世界市場

プラーク修飾および除去デバイスの世界市場は2030年までに30億米ドルに到達

2024年に20億米ドルと推定されるプラーク修飾および除去デバイスの世界市場は、分析期間2024-2030年にCAGR 7.3%で成長し、2030年には30億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアテレクトミーデバイスは、CAGR 8.8%を記録し、分析期間終了時には14億米ドルに達すると予測されます。血栓除去装置セグメントの成長率は、分析期間中CAGR 5.0％と推定されます。

米国市場は5億3,290万米ドルと推定、中国はCAGR11.6％で成長予測

米国のプラーク修飾および除去デバイス市場は、2024年に5億3,290万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに6億3,640万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5%と7.1%と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界のプラーク修飾および除去デバイス市場- 主要動向と促進要因のまとめ

プラーク修飾および除去デバイス市場は、心血管疾患（CVD）患者の増加、低侵襲手技の進歩、カテーテルを用いたプラーク除去手技への嗜好の高まりなどを背景に、大きな成長を遂げています。アテローム性動脈硬化症や末梢動脈疾患（PAD）が蔓延するにつれ、効果的で安全なプラーク除去技術に対するニーズが、特に高齢化した人々や糖尿病、肥満、高血圧の人々の間で高まっています。

市場を形成している主要な動向の1つは、従来の外科的方法と比較して、回復時間の短縮、手技リスクの低減、長期的転帰の改善を提供する低侵襲プラーク除去技術の採用が増加していることです。アテレクトミー装置、レーザーベースのプラーク除去システム、機械的血栓除去ツールはより洗練されつつあり、冠動脈や末梢動脈における正確なターゲティングとより安全なプラーク除去を可能にしています。これらの技術革新は、複雑な石灰化病変、慢性完全閉塞（CTO）、高リスクの心血管疾患を有する患者にとって特に有益です。

市場成長のもう1つの重要な促進要因は、プラーク修正装置に高度な画像技術とナビゲーション技術が統合されたことです。血管内超音波（IVUS）、光干渉断層計（OCT）、リアルタイム血管造影支援ガイダンス・システムは、プラークの特性、病変の評価、手技の精度を高めています。これらの画像診断技術により，心臓専門医や血管外科医はプラークの組成を決定し，器具の選択を最適化し，病変を完全に修正することができ，再狭窄や合併症のリスクを減少させることができます。

さらに、生体吸収性ステントや薬剤コーティングバルーン技術の台頭は、プラーク除去戦略を補完し、血管の持続的な開存と手技後の転帰の改善をもたらしています。規制当局の承認が拡大し、臨床試験で長期的な有効性が実証されていることから、次世代のプラーク除去・修正ソリューションに対する需要は、世界中の病院環境と外来手術センター（ASC）の双方で高まると予想されます。

技術革新はプラーク修正デバイスをどのように変えているか？

プラーク修正業界は、機器の精度、手技リスクの低減、患者の転帰の改善に強く焦点を当てながら、急速な技術進歩を遂げています。次世代アテレクトミー装置、高周波レーザーシステム、機械的吸引血栓除去装置は、複雑で高リスクの患者におけるプラーク除去の有効性を高めています。

この分野における最も注目すべき技術革新の1つは、軌道および回転アテレクトミー装置の開発です。これらのカテーテルベースのシステムは，差動切削技術を用いて，健康な動脈組織の完全性を保ちながら石灰化プラークを選択的に除去します。ダイヤモンドコーティングされたバリと回転エネルギーの使用により、動脈プラークの正確な修正が可能となり、血流が改善され、インターベンションを繰り返す必要性が減少します。

もう一つの画期的な進歩はレーザーを利用したプラーク除去システムであり、高エネルギーレーザーパルスを利用して動脈硬化性プラークを蒸発させる。これらの装置は非常に精度が高く、血管壁への外傷を軽減し、ステント内再狭窄の治療効果を高める。特にエキシマレーザーカテーテルは，複雑な冠動脈インターベンションや末梢インターベンションにおいて，機械的な力を加えることなく石灰化プラークや線維化プラークを制御しながら焼灼することができ，非常に有効であることが証明されつつあります。

機械的およびレーザーベースのアプローチに加えて、超音波増強および衝撃波結石破砕技術が石灰化プラーク修飾の有望な選択肢として台頭してきています。血管内結石破砕術（IVL）は，硬化したプラークを破砕するために音響圧力波を照射し，最小限の血管外傷でプラークの除去を容易にします。この技術は，複雑な心血管インターベンション，特に糖尿病患者や従来の治療に抵抗性を示す重度に石灰化した病変に広く採用されつつあります。

さらに、プラークを標的とした生体工学的ナノ粒子や薬剤溶出プラーク修飾デバイスが、標的プラークの溶解と血管の安定化を提供するために開発中です。これらのナノテクノロジーに基づくソリューションは、手技のリスクを軽減し、炎症反応を最小限に抑え、プラーク除去手技の耐久性を高めると期待されており、今後の研究と臨床応用の重要な焦点となっています。

臨床応用とエンドユーザーの嗜好は、市場の需要をどのように形成しているか？

プラーク修飾および除去デバイスの需要は、末梢動脈疾患（PAD）、頸動脈疾患、冠動脈疾患（CAD）の有病率の増加から大きな影響を受けています。動脈閉塞に対して非外科的介入を求める患者が増える中、病院、心臓血管専門クリニック、外来手術センター（ASC）は、臨床的な需要を満たすために高度なプラーク除去技術を採用しています。

最も急成長している分野の一つは末梢血管インターベンションで、大腿膝窩動脈閉塞や膝窩下動脈閉塞の治療にアテレクトミーやレーザーによるプラーク除去装置が広く使われています。PADは世界中で数百万人が罹患しており、放置すれば重症虚血肢（CLI）や四肢切断の可能性があります。カテーテルを用いたプラーク除去器具が利用可能になったことで、四肢の救命率と長期的な血管の開存性が著しく改善され、これらの器具は現代の血管外科手術に不可欠なものとなっています。

冠動脈インターベンションの分野でも、特にバルーン血管形成術やステント留置術に抵抗性の石灰化冠動脈病変を有する患者において、プラーク修正技術の採用が増加しています。回転アテレクトミー、血管内結石破砕術、レーザーによるプラーク除去は、現在ではリスクの高い経皮的冠動脈インターベンション（PCI）において好ましい選択肢となっており、病変の前処置とステント拡張の成績が向上しています。

もう一つの新たな応用は頸動脈疾患の治療であり，そこではプラーク除去装置が脳卒中や脳血管イベントの予防に役立っています。粥腫切除術と塞栓防止フィルターや薬剤コーティングバルーンを組み合わせたハイブリッドプラーク修正技術は、頸動脈血行再建術の成績を向上させ、遠位塞栓や再狭窄のリスクを低減しています。

さらに、ASCやオフィスベースのラボ（OBL）での外来心臓血管処置の採用が増加していることが、コンパクトで使いやすいプラーク除去装置の需要を促進しています。シングルユースで使い捨てのカテーテルベースのアテレクトミー・システムや費用対効果の高いレーザー・プラットフォームは、同日退院や入院期間の短縮を可能にし、プラーク修正治療をより幅広い患者層にとってより身近で手頃なものにしています。

プラーク修飾および除去デバイス市場の成長を促進する要因は？

プラーク修飾および除去デバイス市場の成長は、低侵襲心血管系処置の進歩、末梢動脈および冠動脈疾患の有病率の増加、リアルタイム画像とAI主導型アナリティクスの統合、外来心血管系治療環境の拡大など、いくつかの要因によって牽引されています。

動脈硬化と心血管疾患（CVD）の世界の負担増は、主要な市場促進要因です。人口の高齢化、座りがちなライフスタイル、代謝障害（糖尿病や肥満など）の増加が続く中、効果的なカテーテルベースのプラーク除去ソリューションへの需要が高まっています。医師は、より安全で、より迅速で、より耐久性のあるインターベンションを求めており、高精度アテレクトミー、レーザーアブレーション、衝撃波結石破砕装置は、現代の心臓血管医療において重要なツールとなっています。

もう1つの主な要因は、AI支援画像処理および手技ナビゲーション・システムの急速な開発です。AIを搭載したプラットフォームは、手技前のプランニング、手技中のガイダンス、手技後のモニタリングを強化し、インターベンショニストが複雑なプラークを検出し、デバイスの選択を最適化し、手技の安全性を向上させることを可能にしています。AIとIVUS、OCT、血管造影との統合により、合併症発生率、再狭窄リスク、手技の失敗が大幅に低減され、市場導入がさらに促進されます。

外来循環器治療の拡大と外来手術センター（ASC）の台頭も市場成長を後押ししています。ヘルスケアシステムが費用対効果の高い即日処置にシフトする中、携帯可能で使いやすいプラーク除去技術への需要が高まっています。各社は、使い捨てアテレクトミー装置、小型レーザーシステム、単回使用結石破砕カテーテルを発売し、病院での治療からオフィスでの治療への移行を支援しています。

さらに、次世代プラーク修正装置の規制当局による承認や臨床試験の成功により、商業化が加速しています。主要企業は、生体吸収性スキャフォールド、ナノテクノロジーに基づくプラーク標的治療、ハイブリッドアテレクトミー・ステントシステムの研究開発（R&D）に投資しており、長期的な血管開存性と心血管健康アウトカムの改善を確実なものにしています。

精密ベースの心血管介入に対する需要が拡大し続ける中、プラーク修飾および除去デバイス市場は、技術の進歩、AI主導の診断、低侵襲治療の革新によって、アテローム性動脈硬化症管理と血管医療の将来を形成し、大きく拡大すると予想されます。

セグメント

製品（アテレクトミーデバイス、血栓除去デバイス、慢性閉塞デバイス、塞栓防止デバイス）;用途（冠動脈疾患、末梢動脈疾患）;最終用途（病院、外来手術センター、その他）

調査対象企業の例

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Plaque Modification and Removal Devices Market to Reach US$3.0 Billion by 2030

The global market for Plaque Modification and Removal Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Atherectomy Devices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Thrombectomy Devices segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$532.9 Million While China is Forecast to Grow at 11.6% CAGR

The Plaque Modification and Removal Devices market in the U.S. is estimated at US$532.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$636.4 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Plaque Modification and Removal Devices Market - Key Trends & Drivers Summarized

The plaque modification and removal devices market is witnessing significant growth, driven by rising cases of cardiovascular diseases (CVDs), advancements in minimally invasive procedures, and increasing preference for catheter-based plaque removal techniques. As atherosclerosis and peripheral artery disease (PAD) become more prevalent, the need for effective and safe plaque removal technologies is growing, particularly among aging populations and individuals with diabetes, obesity, and hypertension.

One of the major trends shaping the market is the increasing adoption of minimally invasive plaque removal techniques, which offer faster recovery times, reduced procedural risks, and improved long-term outcomes compared to traditional surgical methods. Atherectomy devices, laser-based plaque removal systems, and mechanical thrombectomy tools are becoming more sophisticated, enabling precise targeting and safer plaque removal in coronary and peripheral arteries. These innovations are particularly beneficial for patients with complex calcified lesions, chronic total occlusions (CTOs), and high-risk cardiovascular conditions.

Another key driver of market growth is the integration of advanced imaging and navigation technologies in plaque modification devices. Intravascular ultrasound (IVUS), optical coherence tomography (OCT), and real-time angiography-assisted guidance systems are enhancing plaque characterization, lesion assessment, and procedural accuracy. These imaging techniques allow cardiologists and vascular surgeons to determine plaque composition, optimize device selection, and ensure complete lesion modification, reducing the risk of restenosis and complications.

Additionally, the rise of bioresorbable stents and drug-coated balloon technologies is complementing plaque removal strategies, providing sustained vessel patency and improved post-procedural outcomes. With regulatory approvals expanding and clinical trials demonstrating positive long-term efficacy, the demand for next-generation plaque removal and modification solutions is expected to rise in both hospital settings and ambulatory surgical centers (ASCs) worldwide.

How Are Technological Innovations Transforming Plaque Modification Devices?

The plaque modification industry is undergoing rapid technological advancements, with a strong focus on device precision, reduced procedural risks, and improved patient outcomes. Next-generation atherectomy devices, high-frequency laser systems, and mechanical aspiration thrombectomy tools are enhancing the effectiveness of plaque removal in complex and high-risk patients.

One of the most notable innovations in the field is the development of orbital and rotational atherectomy devices. These catheter-based systems use differential cutting technology to selectively remove calcified plaque while preserving the integrity of healthy arterial tissue. The use of diamond-coated burrs and rotational energy allows for precise modification of arterial plaques, improving blood flow and reducing the need for repeat interventions.

Another groundbreaking advancement is laser-based plaque removal systems, which utilize high-energy laser pulses to vaporize atherosclerotic plaques. These devices offer exceptional precision, reduced trauma to vessel walls, and enhanced efficacy in treating in-stent restenosis. Excimer laser catheters, in particular, are proving to be highly effective in complex coronary and peripheral interventions, allowing controlled ablation of calcified and fibrotic plaques without mechanical force.

In addition to mechanical and laser-based approaches, ultrasound-enhanced and shockwave lithotripsy technologies are emerging as promising alternatives for calcified plaque modification. Intravascular lithotripsy (IVL) delivers acoustic pressure waves to fracture hardened plaques, facilitating their removal with minimal vessel trauma. This technique is gaining widespread adoption in complex cardiovascular interventions, particularly in patients with diabetes and heavily calcified lesions that are resistant to traditional treatments.

Moreover, bioengineered plaque-targeting nanoparticles and drug-eluting plaque modification devices are in development to provide targeted plaque dissolution and vessel stabilization. These nanotechnology-based solutions are expected to reduce procedural risks, minimize inflammatory responses, and enhance the durability of plaque removal procedures, making them a key focus for future research and clinical applications.

How Are Clinical Applications and End-User Preferences Shaping Market Demand?

The demand for plaque modification and removal devices is heavily influenced by the increasing prevalence of peripheral artery disease (PAD), carotid artery disease, and coronary artery disease (CAD). As more patients seek non-surgical interventions for arterial blockages, hospitals, specialty cardiovascular clinics, and ambulatory surgical centers (ASCs) are adopting advanced plaque removal technologies to meet clinical demands.

One of the fastest-growing segments is peripheral vascular interventions, where atherectomy and laser plaque removal devices are widely used to treat femoropopliteal and infrapopliteal arterial blockages. PAD affects millions of people worldwide, leading to critical limb ischemia (CLI) and potential limb amputation if left untreated. The availability of catheter-based plaque removal tools has significantly improved limb salvage rates and long-term vessel patency, making these devices essential in modern vascular surgery.

The coronary intervention sector is also seeing increased adoption of plaque modification technologies, particularly in patients with calcified coronary lesions that are resistant to balloon angioplasty and stenting. Rotational atherectomy, intravascular lithotripsy, and laser-assisted plaque removal are now preferred options for high-risk percutaneous coronary interventions (PCIs), offering better lesion preparation and stent expansion outcomes.

Another emerging application is in the treatment of carotid artery disease, where plaque removal devices are helping to prevent stroke and cerebrovascular events. Hybrid plaque modification techniques, combining atherectomy with embolic protection filters and drug-coated balloons, are enhancing carotid revascularization outcomes, reducing the risk of distal embolization and restenosis.

Moreover, the rising adoption of outpatient cardiovascular procedures in ASCs and office-based labs (OBLs) is driving demand for compact, user-friendly plaque removal devices. Single-use, disposable catheter-based atherectomy systems and cost-effective laser platforms are enabling same-day discharge and reduced hospital stays, making plaque modification treatments more accessible and affordable for a broader patient population.

What Factors Are Driving the Growth of the Plaque Modification and Removal Devices Market?

The growth in the plaque modification and removal devices market is driven by several factors, including advancements in minimally invasive cardiovascular procedures, increasing prevalence of peripheral and coronary artery diseases, the integration of real-time imaging and AI-driven analytics, and the expansion of outpatient cardiovascular care settings.

The rising global burden of atherosclerosis and cardiovascular disease (CVD) is a primary market driver. As aging populations, sedentary lifestyles, and metabolic disorders (such as diabetes and obesity) continue to rise, the demand for effective, catheter-based plaque removal solutions is increasing. Physicians are seeking safer, faster, and more durable interventions, making high-precision atherectomy, laser ablation, and shockwave lithotripsy devices critical tools in modern cardiovascular medicine.

Another key factor is the rapid development of AI-assisted imaging and procedural navigation systems. AI-powered platforms are enhancing pre-procedural planning, intraoperative guidance, and post-procedural monitoring, allowing interventionalists to detect complex plaques, optimize device selection, and improve procedural safety. The integration of AI with IVUS, OCT, and angiography is significantly reducing complication rates, restenosis risks, and procedural failures, further driving market adoption.

The expansion of outpatient cardiovascular care and the rise of ambulatory surgical centers (ASCs) are also fueling market growth. With healthcare systems shifting toward cost-effective, same-day procedures, the demand for portable, easy-to-use plaque removal technologies is increasing. Companies are introducing disposable atherectomy devices, compact laser systems, and single-use lithotripsy catheters to support the transition from hospital-based interventions to office-based treatments.

Moreover, regulatory approvals and clinical trial success in next-generation plaque modification devices are accelerating commercialization. Leading companies are investing in research and development (R&D) for bioresorbable scaffolds, nanotechnology-based plaque-targeting therapies, and hybrid atherectomy-stent systems, ensuring long-term vessel patency and improved cardiovascular health outcomes.

As the demand for precision-based cardiovascular interventions continues to grow, the plaque modification and removal devices market is expected to expand significantly, with technological advancements, AI-driven diagnostics, and minimally invasive treatment innovations shaping the future of atherosclerosis management and vascular health care.

SCOPE OF STUDY:

The report analyzes the Plaque Modification and Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices, Embolic Protection Devices); Application (Coronary Artery Disease, Peripheral Artery Disease); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Plaque Modification and Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Peripheral and Coronary Artery Disease Drives Demand for Plaque Modification Devices
  • Increased Use of Endovascular Procedures Spurs Adoption of Atherectomy and Thrombectomy Technologies
  • Technological Innovations in Rotational, Orbital, and Laser-Based Atherectomy Enhance Precision and Efficacy
  • Shift Toward Minimally Invasive Cardiovascular Interventions Strengthens Demand for Plaque Removal Systems
  • Aging Population and Rising Diabetic Patient Base Expand the Target Pool for PAD and CAD Therapies
  • Surge in Complex Lesions and Calcified Arteries Spurs Development of Specialty Modification Devices
  • Regulatory Approvals and Favorable Reimbursement in Developed Markets Accelerate Procedure Volumes
  • Integration of Imaging-Guided and AI-Driven Device Navigation Improves Safety and Clinical Outcomes
  • Hospital Infrastructure Modernization and Hybrid Cath Lab Expansion Support Device Adoption
  • Increasing Adoption of Drug-Coated Balloons and Stents Encourages Pre-Treatment with Debulking Devices
  • Strategic Collaborations Between Medtech Firms and Cardiovascular Specialists Accelerate Innovation
  • Growth of Ambulatory Surgery Centers (ASCs) Enhances Use of Portable and Cost-Efficient Devices
  • Surge in Clinical Trials and Real-World Evidence Supporting Efficacy of Plaque Removal Boosts Physician Confidence
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plaque Modification and Removal Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Atherectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Chronic Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• JAPAN
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CHINA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• EUROPE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• FRANCE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• GERMANY
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• INDIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AFRICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION